PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $971,816 | -18.0% | 439,736 | -5.8% | 0.00% | – |
| Q1 2023 | $1,185,659 | +136496.7% | 466,795 | +0.5% | 0.00% | – |
| Q4 2022 | $868 | -99.9% | 464,437 | +5.1% | 0.00% | – |
| Q3 2022 | $1,135,000 | +34.8% | 441,935 | +1.3% | 0.00% | – |
| Q2 2022 | $842,000 | -64.8% | 436,319 | -45.9% | 0.00% | – |
| Q1 2022 | $2,394,000 | -29.9% | 806,113 | +6.0% | 0.00% | – |
| Q4 2021 | $3,416,000 | +0.8% | 760,816 | +9.1% | 0.00% | – |
| Q3 2021 | $3,390,000 | -31.4% | 697,621 | -3.7% | 0.00% | -100.0% |
| Q2 2021 | $4,940,000 | +0.7% | 724,407 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $4,906,000 | +23.5% | 695,015 | +9.5% | 0.00% | 0.0% |
| Q4 2020 | $3,972,000 | +24.3% | 634,660 | +7.5% | 0.00% | 0.0% |
| Q3 2020 | $3,195,000 | +4.4% | 590,647 | +0.8% | 0.00% | 0.0% |
| Q2 2020 | $3,059,000 | +69.4% | 586,107 | +2.2% | 0.00% | – |
| Q1 2020 | $1,806,000 | -52.8% | 573,398 | -39.7% | 0.00% | – |
| Q4 2019 | $3,826,000 | +117.9% | 950,458 | +133.8% | 0.00% | – |
| Q3 2019 | $1,756,000 | +12.0% | 406,513 | +3.4% | 0.00% | – |
| Q2 2019 | $1,568,000 | -13.8% | 393,022 | +15.8% | 0.00% | – |
| Q1 2019 | $1,819,000 | -42.6% | 339,492 | -45.0% | 0.00% | – |
| Q4 2018 | $3,168,000 | +8.2% | 617,546 | +104.5% | 0.00% | -100.0% |
| Q3 2018 | $2,929,000 | +0.4% | 301,962 | +5.6% | 0.00% | 0.0% |
| Q2 2018 | $2,917,000 | -13.3% | 286,060 | +10.5% | 0.00% | 0.0% |
| Q1 2018 | $3,366,000 | -6.3% | 258,965 | +29.0% | 0.00% | 0.0% |
| Q4 2017 | $3,593,000 | -26.8% | 200,782 | +2.6% | 0.00% | -50.0% |
| Q3 2017 | $4,909,000 | +7.5% | 195,631 | +3.3% | 0.00% | 0.0% |
| Q2 2017 | $4,565,000 | +59.2% | 189,447 | +27.2% | 0.00% | +100.0% |
| Q1 2017 | $2,867,000 | +38.4% | 148,962 | +10.7% | 0.00% | 0.0% |
| Q4 2016 | $2,072,000 | +32.1% | 134,570 | +11.5% | 0.00% | 0.0% |
| Q3 2016 | $1,569,000 | +109.8% | 120,639 | +124.2% | 0.00% | – |
| Q2 2016 | $748,000 | -3.1% | 53,811 | +5.6% | 0.00% | – |
| Q1 2016 | $772,000 | -16.3% | 50,943 | +4.7% | 0.00% | -100.0% |
| Q4 2015 | $922,000 | +1.9% | 48,654 | +2.1% | 0.00% | 0.0% |
| Q3 2015 | $905,000 | -21.9% | 47,641 | +5.9% | 0.00% | 0.0% |
| Q2 2015 | $1,159,000 | +251.2% | 44,992 | +325.6% | 0.00% | – |
| Q1 2015 | $330,000 | -13.2% | 10,572 | +7.2% | 0.00% | – |
| Q4 2014 | $380,000 | – | 9,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|